Auro Laboratories Ltd.
Snapshot View

71.00 -0.30 ▼-0.4%

27 January 2023, 04:01:00 PM
Volume: 3,141

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aurolabs.com
Market Cap 44.25 Cr.
Enterprise Value(EV) 47.71 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.18 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 32.51 Trailing Twelve Months Ending 2022-09
Industry PE 33.61 Trailing Twelve Months Ending 2022-09
Book Value / Share 51.26 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.39 Calculated using Price: 71.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.62 Cr. 6,232,500 Shares
FaceValue 10
Company Profile
Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. The company is promoted by Shri Sharat Deorah and Shri Satish Deorah.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.42%
1 Week
-3.79%
1 Month
-6.70%
3 Month
-7.73%
6 Month
-17.63%
1 Year
-38.95%
2 Year
-24.99%
5 Year
-13.41%
10 Year
+610.0%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 8.76 11.01 10.83 9.06 31.53 28.95 20.84 28.67 9.47
Return on Capital Employed (%) 9.40 10.76 11.21 20.24 28.65 29.12 24.80 38.88 12.20
Return on Assets (%) 2.04 2.89 3.24 3.11 12.34 13.78 12.32 19.34 5.87

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 7 8 9 9 13 17 22 29 32 32
Non Curr. Liab. 7 8 7 11 8 6 5 4 3 5
Curr. Liab. 13 14 10 6 10 10 6 9 20 16
Minority Int.
Equity & Liab. 27 29 26 27 30 33 32 42 55 53
Non Curr. Assets 11 11 13 13 15 15 14 14 18 18
Curr. Assets 16 18 12 14 16 19 18 28 37 34
Misc. Exp. not W/O
Total Assets 27 29 26 27 30 33 32 42 55 53

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 34 33 28 35 41 47 44 54 51 54
Other Income 0 0 0 1 1 1 1 1 1 0
Total Income 34 33 28 36 41 48 45 55 52 54
Total Expenditure -31 -30 -25 -31 -34 -40 -38 -43 -46 -50
PBIDT 3 3 3 5 7 8 7 12 6 4
Interest -2 -2 -2 -1 -1 -1 -1 0 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -2 -1 -2 -2 -3 -1 0
Exceptional Items
PAT 1 1 1 1 4 4 4 7 3 1
Adjusted EPS 1 1 1 1 6 7 7 12 5 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 4 -1 8 6 5 7 9 13 -7
Cash Fr. Inv. -1 -1 -1 -2 -2 -2 -3 -2 -4 -5
Cash Fr. Finan. -1 -3 1 -5 -4 -2 -2 -6 0 10
Net Change 0 1 -1 0 0 1 2 2 9 -2
Cash & Cash Eqvt 0 1 0 1 1 2 4 6 15 12

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 51.92 51.92 51.92 51.92 51.93 51.99 51.99 52.09 52.09
Public 48.08 48.08 48.08 48.08 48.07 48.01 48.01 47.91 47.91
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 16 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
The details of securities dematerialized during the quarter ended December 31 2022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 have been furnished to all the stock exchanges where the shares ofthe Company are listed.
Thu, 29 Dec 2022
Closure of Trading Window
Pursuant to Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with BSE Circular Ref No. LIST/COMP/01/2019-20 dated April 2 2019 and Companys Code of Conduct to regulate monitor and report trading in Companys Securities by Insiders we wish to inform you that the Trading Window for dealing in the securities of theCompany will remain closed for all Designated Persons (as defined in the Code) w.e.f. January 01 2023 for the purpose of consideration of unaudited Financial Results for the Quarterended December 31 2022.The Trading Window shall open 48 hours after the unaudited Financial Results for the Quarter ended December 31 2022 become generally available.The date of Board meeting of the Company for consideration and declaration of the said results will be intimated in due course.
Fri, 23 Dec 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuance to Regulation 39(3) of the SEBI Regulations we wish to inform you that the belowmentioned share certificates have been reported to be lost/ misplaced. Further the Company hasreceived request from the holder of the Shares to issue Duplicate Share Certificates in lieu of theoriginal Share Certificates reported lost/ misplaced

Technical Scans View Details >>

Wed, 25 Jan 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.75 +0.1%
Divi's Laboratories Ltd. 88,552.35 3,385.55 +1.5%
Cipla Ltd. 83,862.25 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,497.96 1,537.85 -1.3%
Abbott India Ltd. 45,101.64 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 32.68 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.15 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 3.83 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.62 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Auro Laboratories Ltd.

What is Auro Laboratories share price?

Can I buy Auro Laboratories shares now?

What is the Market Cap of Auro Laboratories?

What are the key metrics to analyse Auro Laboratories?

What is the 52 Week High and Low of Auro Laboratories?

What is the trend of Auro Laboratories share price?